Journal Article
Rummler, M.; Schemenz, V.; McCluskey, S.; Davydok, A.; Rauch, F.; Glorieux, F. H.; Harrington, M. J.; Wagermaier, W.; Willie, B. M.; Zimmermann, E. A.: Bone matrix properties in adults with osteogenesis imperfecta are not adversely affected by setrusumab—a sclerostin neutralizing antibody. Journal of Bone and Mineral Research
39 (9), pp. 1229 - 1239 (2024)